Hong Zhu - Concepedia

Author

Hong Zhu

The University of Texas Southwestern Medical Center ORCID

Also Known As

H Zhu, H. Zhu, Hong ZHU, Hong Zhu, Huiyuan Zhu, Zhu Hong, Zhu, Hong

185

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center VA North Texas Health Care System

About

Hong Zhu is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	887
2	Public Health	6	6	102
3	Biostatistics	4	4	159
4	Engineering	2	2	119
5	Nursing	1	1	14

Hong Zhu

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis Ali A. Mokdad, Rebecca M. Minter, Hong Zhu, Journal of Clinical Oncology Neoadjuvant Therapy FollowedSurgical OncologyPancreatic CancerCancer EpidemiologyOverall Survival	2016	393
Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection Patricio M. Polanco, Ali A. Mokdad, Hong Zhu, JAMA Oncology	2018	114
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer Jae‐Ho Cheong, Sam C. Wang, Sunho Park, Nature Communications EngineeringPredictive 32-Gene SignaturePrognosisGastroenterologyPathology	2022	109
Open, Laparoscopic, and Robotic Inguinal Hernia Repair: Outcomes and Predictors of Complications Sergio Huerta, Corey Timmerman, Madison Argo, Journal of Surgical Research LaparoscopyHernia SurgeryMinimally Invasive ProcedureOpen ProcedureSurgery	2019	75
Sample size considerations for split-mouth design Hong Zhu, Song Zhang, Chul Ahn Statistical Methods in Medical Research	2015	69
Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis Ali A. Mokdad, Hong Zhu, Jorge A. Marrero, The American Journal of Gastroenterology	2016	51
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer David E. Gerber, David A. Boothman, Farjana Fattah, Lung Cancer MedicinePharmacologyAnti-cancer AgentOncologyRadiation Oncology	2015	47
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer Yaru Xu, Yuqiu Yang, Zhaoning Wang, Cancer Discovery	2024	39
Timing, Sites, and Correlates of Lung Cancer Recurrence Chelsea M. Karacz, Jingsheng Yan, Hong Zhu, Clinical Lung Cancer Cancer EpidemiologyMedicineCancer RecurrenceEpidemiology Of CancerLung Cancer Recurrence	2019	38
Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients Rita Saynhalath, Gijo Alex, Proshad N. Efune, Anesthesia & Analgesia	2021	37

Page 1